GMALY yields 3.06% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 5
Combined, GMALY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GMALY + JNJ for your $10,000?
Genting Malaysia Berhad, together with its subsidiaries, engages in the leisure and hospitality business in Malaysia, the United Kingdom, Egypt, the United States, and the Bahamas. It operates through Leisure & Hospitality, and Properties segments. The Leisure & Hospitality segment comprises integrated resort activities, which include gaming, hotels, food and beverage, theme parks, and retail and entertainment attractions, as well as tours and travel related, and other supporting services. The Properties segment is involved in the development and sale of land and properties, as well as letting of apartment units; and property investment and management activities. It also engages in the operation of casinos; and provision of information technology and consultancy services. In addition, the company provides investment, marketing, private debt securities issuance, training, administrative, show agency, condotel, golf resort, cable car and related support, creative and art, project and construction management, offshore financing, karaoke, payment and collection agency, loyalty programme, garbage collection and disposal, sewerage, investment trading, reinsurance, and resort management services. Further, it offers electricity supply, water, liquefied petroleum gas, and other services at Genting Highlands; operates sportsbooks; owns and operates aircraft; owns sea vessels; researches and develops software; and operates a video lottery facility. The company was formerly known as Resorts World Bhd. Genting Malaysia Berhad was incorporated in 1980 and is headquartered in Kuala Lumpur, Malaysia
Full GMALY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.